Fig. 3.

Hazard ratio plots of independent predictors with the multivariable analyses for death or myocardial infarction in 30 days in UFH and LMWH groups with glycoprotein IIb/IIIa inhibitor (A) and without glycoprotein IIb/IIIa inhibitor (B) in STEMI patients who underwent primary PCI.

^*Defined as coronary heart disease in first-degree male relative <55 yr old or coronary heart disease in first-degree female relative <65 yr old.

LMWH, low molecular weight heparin; UFH, unfractionated heparin; STEMI, ST-elevation myocardial infarction; PCI, percutaneous coronary intervention.